140 related articles for article (PubMed ID: 18506377)
1. PPARdelta increases expression of the human apolipoprotein A-II gene in human liver cells.
Thulin P; Glinghammar B; Skogsberg J; Lundell K; Ehrenborg E
Int J Mol Med; 2008 Jun; 21(6):819-24. PubMed ID: 18506377
[TBL] [Abstract][Full Text] [Related]
2. Identification of a functional peroxisome proliferator-activated receptor (PPAR) response element (PPRE) in the human apolipoprotein A-IV gene.
Nagasawa M; Hara T; Kashino A; Akasaka Y; Ide T; Murakami K
Biochem Pharmacol; 2009 Sep; 78(5):523-30. PubMed ID: 19433068
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT/enhancer binding protein-beta.
Brunelli L; Cieslik KA; Alcorn JL; Vatta M; Baldini A
Circ Res; 2007 Mar; 100(5):e59-71. PubMed ID: 17303761
[TBL] [Abstract][Full Text] [Related]
4. Carbacyclin induces carnitine palmitoyltransferase-1 in cardiomyocytes via peroxisome proliferator-activated receptor (PPAR) delta independent of the IP receptor signaling pathway.
Kuroda T; Hirota H; Fujio Y; Sugiyama S; Masaki M; Hiramoto Y; Shioyama W; Okamoto K; Hori M; Yamauchi-Takihara K
J Mol Cell Cardiol; 2007 Jul; 43(1):54-62. PubMed ID: 17540403
[TBL] [Abstract][Full Text] [Related]
5. AP1-dependent repression of TGFα-mediated MMP9 upregulation by PPARδ agonists in keratinocytes.
Meissner M; Berlinski B; Doll M; Hrgovic I; Laubach V; Reichenbach G; Kippenberger S; Gille J; Kaufmann R
Exp Dermatol; 2011 May; 20(5):425-9. PubMed ID: 21496113
[TBL] [Abstract][Full Text] [Related]
6. A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation.
Shende VR; Singh AB; Liu J
Biochem J; 2015 Dec; 472(3):275-86. PubMed ID: 26443862
[TBL] [Abstract][Full Text] [Related]
7. The human semaphorin 6B gene is down regulated by PPARs.
Collet P; Domenjoud L; Devignes MD; Murad H; Schohn H; Dauça M
Genomics; 2004 Jun; 83(6):1141-50. PubMed ID: 15177567
[TBL] [Abstract][Full Text] [Related]
8. Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells.
Cao A; Li H; Zhou Y; Wu M; Liu J
J Biol Chem; 2010 May; 285(22):16664-74. PubMed ID: 20308079
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta1 is a molecular target for the peroxisome proliferator-activated receptor delta.
Kim HJ; Ham SA; Kim SU; Hwang JY; Kim JH; Chang KC; Yabe-Nishimura C; Kim JH; Seo HG
Circ Res; 2008 Feb; 102(2):193-200. PubMed ID: 18007025
[TBL] [Abstract][Full Text] [Related]
10. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection.
Burger-van Paassen N; Vincent A; Puiman PJ; van der Sluis M; Bouma J; Boehm G; van Goudoever JB; van Seuningen I; Renes IB
Biochem J; 2009 May; 420(2):211-9. PubMed ID: 19228118
[TBL] [Abstract][Full Text] [Related]
11. Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts.
Teunissen BE; Smeets PJ; Willemsen PH; De Windt LJ; Van der Vusse GJ; Van Bilsen M
Cardiovasc Res; 2007 Aug; 75(3):519-29. PubMed ID: 17543901
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.
Chen W; Wang LL; Liu HY; Long L; Li S
Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):240-6. PubMed ID: 18684227
[TBL] [Abstract][Full Text] [Related]
13. NRF-2 transcription factor is required for human TOMM20 gene expression.
Blesa JR; Prieto-Ruiz JA; Hernández JM; Hernández-Yago J
Gene; 2007 Apr; 391(1-2):198-208. PubMed ID: 17300881
[TBL] [Abstract][Full Text] [Related]
14. The PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition.
Kino T; Rice KC; Chrousos GP
Eur J Clin Invest; 2007 May; 37(5):425-33. PubMed ID: 17461989
[TBL] [Abstract][Full Text] [Related]
15. Contribution of the hormone-response elements of the proximal ApoA-I promoter, ApoCIII enhancer, and C/EBP binding site of the proximal ApoA-I promoter to the hepatic and intestinal expression of the ApoA-I and ApoCIII genes in transgenic mice.
Kan HY; Georgopoulos S; Zanni M; Shkodrani A; Tzatsos A; Xie HX; Zannis VI
Biochemistry; 2004 May; 43(17):5084-93. PubMed ID: 15109267
[TBL] [Abstract][Full Text] [Related]
16. Regulation of human hepatocyte gene expression by fatty acids.
Swagell CD; Henly DC; Morris CP
Biochem Biophys Res Commun; 2007 Oct; 362(2):374-80. PubMed ID: 17707340
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells.
Turner EC; Kinsella BT
J Mol Biol; 2009 Feb; 386(3):579-97. PubMed ID: 19118563
[TBL] [Abstract][Full Text] [Related]
18. PPARdelta in humans: genetic and pharmacological evidence for a significant metabolic function.
Karpe F; Ehrenborg EE
Curr Opin Lipidol; 2009 Aug; 20(4):333-6. PubMed ID: 19512923
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of the antiproliferative effect of beraprost, a prostacyclin agonist, in murine vascular smooth muscle cells.
Lin H; Lee JL; Hou HH; Chung CP; Hsu SP; Juan SH
J Cell Physiol; 2008 Feb; 214(2):434-41. PubMed ID: 17620284
[TBL] [Abstract][Full Text] [Related]
20. PPARbeta/delta agonist increases the expression of PGE2 receptor subtype EP4 in human lung carcinoma cells.
Ritzenthaler JD; Roman J; Han S
Methods Mol Biol; 2009; 512():309-23. PubMed ID: 19347285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]